Search Results
Dec 09, 2025, 15:00 ET Forbes Names TransCrypts CEO Zain Zaidi to 2026 30 Under 30 List After $15M USD Seed Round and Toronto HQ Launch
deployments demonstrated the platform's global applicability and shaped the next phase of TransCrypts' evolution. After early success in employment and HR verification, they are expanding into healthcare. The company recently achieved
More news about: TransCrypts
Dec 09, 2025, 14:40 ET AZIO Corp Unveils AZIO AI, an Independent High-Performance Computing Company, Following Rapid Expansion and $50 Million Sales Pipeline in First 60 Days
public-sector technology programsMedia, VFX, and entertainment studios using high-density GPU render pipelinesEnterprise AI teams and HR analytics platformsTechnology companies scaling model training and edge-AI workloads Transition to a Standalone Global Technology
More news about: Azio AI Corporation
Dec 09, 2025, 14:24 ET Menarini Group 於 2025 年聖安東尼奧乳癌研討會公佈 Elacestrant (ORSERDU®) 針對 ER+、HER2- 轉移性乳癌 (mBC) 患者的第 2 期聯合治療數據
抑制劑及內分泌治療產生抗藥性的 HR+/HER2-低表達 (low) 或 HER2-超低表達 (ultralow) 轉移性乳癌患者。摘要編號：2119發表日期及時間：2025 年 12 月 12 日（星期五），下午 12:30 – 2:00地點： Henry B. Convention Center發表演講者：Sara L. Sammons簡報題目：術前接受 Elacestrant 及 PULSAR 自適應放射治療的荷爾蒙受體 (HR) 陽性 HER2 陰性乳癌患者：一項第
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 13:57 ET Retailers Risk Falling Behind Without a Clear Store Modernization Strategy, Warns Info-Tech Research Group
Info-Tech Research Group is one of the world's leading and fastest-growing research and advisory firms, serving over 30,000 IT, HR, and marketing professionals around the globe. As a trusted product and service leader, the company delivers unbiased, highly relevant research and industry-leading
More news about: Info-Tech Research Group
Dec 09, 2025, 13:00 ET Emmanuelle Migneault to succeed Maryse Fernet as Chief Human Resources Officer of Cascades
been at the heart of many strategic projects that have shaped who we are today. She was the architect behind the implementation and modernization of our HR processes. She is an inspiring leader, a mentor to many, and above all, one of the guardians of our culture and values, which she has always defended
More news about: Cascades Inc.
Dec 09, 2025, 12:30 ET Lattice Welcomes Amy Christensen as Chief Revenue Officer
GrowthSAN FRANCISCO, Dec. 9, 2025 /PRNewswire/ -- Lattice, the leading HR platform where people and AI succeed together, today announced the appointment of Amy Christensen as Chief Revenue Officer. Christensen brings extensive
More news about: Lattice
Dec 09, 2025, 11:38 ET El Grupo Menarini presenta datos de la combinación de fase 2 de Elacestrant (ORSERDU®) en cáncer de mama
patients with CDK4/6 inhibitor and endocrine-resistant HR+/HER2-low or HER2-ultralow metastatic breast cáncer (ERADICATE: Un estudio de fase Ib/II de elacestrant más trastuzumab deruxtecan en pacientes con inhibidor de CDK4/6 y cáncer de mama metastásico HR+/HER2-bajo o HER2-ultrabajo endocrinorresistente)Número
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 10:34 ET McLean & Company Releases HR Trends Report for 2026: Highlights Growing Gap Between Organizational Change and Leadership Capacity
tools with deep HR expertise to position organizations to meet today's needs and prepare for the future. The global HR research and advisory firm's member organizations enjoy comprehensive resources, full-service diagnostics, workshops, action plans, and advisory services for all levels of HR professionals,
More news about: McLean & Company
Dec 09, 2025, 10:03 ET ADP Announces 2026 HCM Distinction Award Finalists
ROSELAND, N.J., Dec. 9, 2025 /PRNewswire/ -- ADP, a global leader in HR and payroll solutions, today announced the finalists for the 2026 HCM Distinction Awards. Celebrating the transformation of work, the awards program
More news about: ADP, Inc.
Dec 09, 2025, 10:01 ET Workforce Management Market worth $13.03 billion by 2030 | MarketsandMarkets™
automation further increases the need for ongoing technical expertise and customized configuration. Additionally, enterprises facing skill gaps in IT and HR technology management prefer outsourcing maintenance, system updates, and performance tuning to service providers. Managed services are also gaining
More news about: MarketsandMarkets
Dec 09, 2025, 10:00 ET Preferred Rate Mortgage Validates Remote Productivity, Cuts Costs and Boosts Earnings Potential with ActivTrak
Workforce PlanningActivTrak also became central to strategic workforce planning. Shared visibility into work patterns allowed Preferred Rate's HR, finance and operations teams to align on capacity needs and resource allocation, giving leadership the agility needed to handle the mortgage industry's
More news about: ActivTrak
Dec 09, 2025, 09:49 ET 메나리니 그룹, 2025 샌안토니오 유방암 심포지엄에서 엘라세스트란트(ORSERDU)®의 ER+, HER2- 전이성 유방암(mBC) 환자 대상 2상 병용 요법 데이터 발표
제목: ERADICATE: CDK4/6 억제제 및 내분비 치료 내성이 있는 HR+/HER2-low 또는 HER2-ultralow 전이성 유방암 환자에서 엘라세스트란트 + 트라스투주맙 데룩스테칸(trastuzumab deruxtecan) 병용의 1b/2상 연구(ERADICATE: A phase Ib/II study of elacestrant plus trastuzumab deruxtecan in patients with CDK4/6 inhibitor and endocrine-resistant HR+/HER2-low or HER2-ultralow metastatic
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 09, 2025, 09:23 ET Rasa Legal Brings Affordable Criminal Record Sealing Technology to Pennsylvania
retention and second-chance hiring initiatives. Research shows 12% higher retention rates among employees with records, and 85% of HR professionals report that workers with criminal histories perform as well or better than other employees. About
More news about: Rasa Legal
Dec 09, 2025, 09:00 ET iCIMS Named #1 in ATS Market Share by APPS RUN THE WORLD
consecutive year in the 2025-2026 Annual HR Systems Voice of the Customer (VoC) Survey Report.Nucleus Research named iCIMS a leader in the Standalone TA Technology Value Matrix 2025 for the sixth consecutive year.Last month, iCIMS was also named an "HR AI Innovator" in the
More news about: iCIMS, Inc.
Dec 09, 2025, 09:00 ET ParentSquare Expands Rapidly in Kentucky as School Districts Prioritize Clear, Consistent, and Compliant Communication
effectively—and families trusted the platform. SB 181 validated what we were already doing right."Reflecting on SB 181, Tiffany Blazina, Director of HR and PR at Crittenden County Schools, said, "I didn't know this was going to land in our laps. But I was incredibly thankful we had ParentSquare in place.
More news about: ParentSquare
Dec 09, 2025, 08:15 ET ADP National Employment Report Preliminary Estimate for November 22, 2025
https://www.adpresearch.com.About ADP (NASDAQ: ADP)ADP has been shaping the world of work with innovation and expertise for more than 75 years. As a global leader in HR and payroll solutions, ADP continuously works to solve business challenges for our clients and their workers, from simple, easy-to-use tools for small
More news about: ADP, Inc.
Dec 09, 2025, 08:00 ET A Wake-up Call for Executives: Three Critical Trends That Will Reshape Leadership
assessment and contextual insights, our platform surfaces high-impact talent signals and turns them into clear, personalized actions HR can take—quickly and effectively. HR teams turn to SuccessFinder not for assessment reports, but for the intelligence they need to engage leaders, build strong teams, scale
More news about: SuccessFinder
Dec 09, 2025, 07:44 ET Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plus DARZALEX FASPRO® as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma
Results show an 83% reduction in the risk of disease progression or death compared to standard regimens at nearly three-years follow-up (hazard ratio [HR], 0.17; 95 percent confidence interval [CI], 0.12-0.23; P<0.0001).1 Ninety-one percent of patients who were progression-free at six months
More news about: Johnson & Johnson
Dec 09, 2025, 07:30 ET Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
(CLL/SLL) without 17p deletions. Pirtobrutinib met its primary endpoint demonstrating a reduction in the risk of disease progression or death by 80% (HR=0.20 [95% CI, 0.11-0.37]; p<0.0001).
More news about: Eli Lilly and Company
Dec 09, 2025, 04:00 ET ezW2 2025 Now Offering W2 and 1099 E-File Service Add-On!
Also available is ezW2 2025 Enterprise Multiple-user Network Version for Windows, starting at $119 for two installations.Accountants, HR teams, e-commerce businesses, and SMBs alike continue to choose ezW2 for its exceptional quality and affordable pricing.Comprehensive
More news about: Halfpricesoft.com
Dec 09, 2025, 00:00 ET Latest Women in the Workplace Report Reveals Corporate America Risks Rolling Back Progress for Women
we collected pipeline data from 124 organizations employing approximately 3 million people, surveyed 70 companies on their HR policies and practices, conducted interviews with 62 HR executives, and collected insights from 9,500+ employees.ABOUT MCKINSEY & COMPANYMcKinsey is a
More news about: LeanIn.Org
Dec 08, 2025, 21:02 ET Significant Improvement in Quality of Life Reported in Updated HARMONi-6 Data for Ivonescimab at ESMO Asia
maintain better overall health status. Time to deterioration in "Global Health Status/Quality of Life" was meaningfully delayed in the ivonescimab arm (HR = 0.94), indicating a trend toward reduced risk of QoL worsening versus the control group.The ivonescimab-based regimen met the primary PFS
More news about: Akeso, Inc.
Dec 08, 2025, 15:17 ET Le groupe Menarini présente les données de la phase 2 sur l'association d'Elacestrant (ORSERDU®) chez des patientes atteintes d'un cancer du sein métastatique (mBC) ER+, HER2- lors du 2025 San Antonio Breast Cancer Symposium
l'elacestrant associé au trastuzumab deruxtecan chez des patientes atteintes d'un cancer du sein métastatique avec inhibiteur CDK4/6 et résistant à l'endocrine, HR+/HER2-faible ou HER2-ultralowNuméro de l'abrégé : 2119Date et heure de la présentation : Vendredi 12 décembre 2025, 12h30
More news about: Menarini Industrie Farmaceutiche Riunite
Dec 08, 2025, 15:06 ET Why AI Investments Stall: New Guidance on Data Operating Models Published by Info-Tech Research Group
Info-Tech Research Group is one of the world's leading and fastest-growing research and advisory firms, serving over 30,000 IT, HR, and marketing professionals around the globe. As a trusted product and service leader, the company delivers unbiased, highly relevant research and industry-leading
More news about: Info-Tech Research Group
Dec 08, 2025, 14:47 ET Menarini Group präsentiert Daten zur Phase-2-Kombination von Elacestrant (ORSERDU®) bei Patientinnen mit ER+, HER2- metastasiertem Brustkrebs (mBC) auf dem San Antonio Breast Cancer Symposium 2025
Präsentation: ERADICATE: Eine Phase-Ib/II-Studie von Elacestrant plus Trastuzumab-Deruxtecan bei Patientinnen mit CDK4/6-Inhibitor- und endokrinresistentem HR+/HER2-armem oder HER2-ultralarmem metastasiertem BrustkrebsAbstract Number: 2119Datum und Uhrzeit der Präsentation: Freitag,
More news about: Menarini Industrie Farmaceutiche Riunite